Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models.

Background: Even though many oral glucose-lowering or lipid-lowering agents have already been reported to improve hepatic steatosis to some degree, which drug had a more beneficial effect on hepatic steatosis among those drugs has not been precisely explored. We analysed the effect of empagliflozi, a selective sodium-glucose cotransporter 2 inhibitor, and ezetimibe on developing hepatic steatosis.

Methods And Results: Using 4005,779 patients with type 2 diabetes mellitus (T2DM) or dyslipidemia provided by the Korean National Health Insurance Service (NHIS) between January 2015 and December 2015, we analyzed the odds ratio (OR) of fatty liver development (fatty liver index [FLI] >60).

Clinical review of endogenous endophthalmitis in Korea: a 14-year review of culture positive cases of two large hospitals.

Purpose: To identify the clinical features and outcomes of endogenous endophthalmitis in Korea.

Materials And Methods: We reviewed 18 patients with endogenous endophthalmitis at 2 Korean hospitals, treated over a 14 year period between January 1993 and December 2006.

Results: The comorbidities observed in these cases were diabetes mellitus and liver cirrhosis.